# ALBENZA
> **NDA020666** · New Drug Application · Sponsor: IMPAX LABS INC · Approved 1996-06-11
## Drug
- **FDA Application Number:** NDA020666
- **Application type:** New Drug Application
- **Brand name:** ALBENZA
- **Generic name:** ALBENDAZOLE
- **Active ingredients:** ALBENDAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** IMPAX LABS INC
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 1996-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020666)
---
*MORVS · CC0 1.0*